Cure8 research brief
The study links a gut microbe (F. nucleatum) and its metabolite succinic acid to inflammatory activation of intestinal macrophages—an immune mechanism that can worsen colitis. Understanding this pathway could point toward new therapeutic targets for IBD.
Researchers studying IBD mechanisms or the microbiome, clinicians interested in emerging IBD biology, and patients or advocates following microbiome-targeted therapies or immunologic research.
The paper integrates human fecal and mucosal data with multiple animal colitis models and bacterial genetics to show that F. nucleatum increases succinic acid levels.
Succinic acid upregulates the macrophage receptor SUCNR1, activates NF-κB, and promotes a pro-inflammatory macrophage phenotype associated with epithelial barrier disruption and worse colitis in experimental models. A fumarate reductase–deficient F.
nucleatum strain with reduced succinate production had less ability to activate macrophages and aggravate colitis; adding succinic acid back restored these effects. Blocking SUCNR1 expression or inhibiting NF-κB reduced succinic acid–induced macrophage activation, supporting the proposed SUCNR1–NF-κB axis.
This is preclinical/basic-science research combining human sample observations with animal and cellular models. While the pathway is plausible and well-supported experimentally, it does not demonstrate clinical benefit from any specific intervention in people.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Intestinal fibrosis and strictures remain a major cause of surgery and obstruction in Crohn’s disease, and current anti-inflammatory drugs don’t reliably prevent fibrosis. If microbial choline degradation promotes...
If true, a common gut microbe (Fusobacterium nucleatum) and its metabolite succinic acid could worsen intestinal inflammation by changing macrophage behavior, suggesting new targets to reduce flares or mucosal injury in...
The paper proposes a specific molecular link between elevated glycocholic acid (a bile acid altered in IBD) and impaired intestinal stem cell renewal via the TRIB3–ID1 pathway, which could help explain poor mucosal...
